Polio Eradication Goal Extended

Luis Fermin Tenorio, the last polio case in the Western hemisphere The goal to eradicate polio by the end of 2000 remains elusive, and the amount of time left in this month won't change that. On Sept. 27, the World Health Organization (WHO), the Centers for Disease Control and Prevention, Rotary International, UNICEF, and various private donors announced at the Polio Partners Summit held at the United Nations that they are joining forces to intensify the eradication campaign, with a new deadline

Written byRicki Lewis
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


Luis Fermin Tenorio, the last polio case in the Western hemisphere
The goal to eradicate polio by the end of 2000 remains elusive, and the amount of time left in this month won't change that. On Sept. 27, the World Health Organization (WHO), the Centers for Disease Control and Prevention, Rotary International, UNICEF, and various private donors announced at the Polio Partners Summit held at the United Nations that they are joining forces to intensify the eradication campaign, with a new deadline of 2005.

Worldwide eradication efforts may be stymied, however, by Mother Nature. Recent reports indicate that not only is wild poliovirus still around, but that vaccine strains can mutate into potentially infectious forms. "The existence of virulent strains in the environment means that individuals are excreting these strains from their guts. But as long as immunization coverage is well maintained, oral polio vaccine or inactive polio vaccine is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies